Head to Head Analysis: Scripsamerica (OTCMKTS:SCRCQ) vs. STAAR Surgical (NASDAQ:STAA)

STAAR Surgical (NASDAQ:STAA) and Scripsamerica (OTCMKTS:SCRCQ) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, risk, earnings, institutional ownership, analyst recommendations, valuation and profitability.

Valuation & Earnings

This table compares STAAR Surgical and Scripsamerica”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
STAAR Surgical	$313.90 million	4.24	-$20.21 million	($1.44)	-18.68
Scripsamerica	N/A	N/A	N/A	N/A	N/A

Scripsamerica has lower revenue, but higher earnings than STAAR Surgical.

Profitability

This table compares STAAR Surgical and Scripsamerica’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
STAAR Surgical	-25.46%	-10.59%	-8.32%
Scripsamerica	N/A	N/A	N/A

Analyst Ratings

This is a breakdown of current ratings and price targets for STAAR Surgical and Scripsamerica, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
STAAR Surgical	0	10	1	0	2.09
Scripsamerica	0	0	0	0	0.00

STAAR Surgical presently has a consensus target price of $21.7143, indicating a potential downside of 19.28%. Given Scripsamerica’s higher probable upside, analysts plainly believe Scripsamerica is more favorable than STAAR Surgical.

Institutional & Insider Ownership

96.7% of STAAR Surgical shares are held by institutional investors. 1.0% of STAAR Surgical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

STAAR Surgical beats Scripsamerica on 5 of the 9 factors compared between the two stocks.

About STAAR Surgical

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

About Scripsamerica

ScripsAmerica, Inc. develops and sells non-sterile topical and transdermal pain creams. The company also provides pharmacy dispensing services for individual doctors, as well as billing and administrative services to independent pharmacies. In addition, it distributes pharmaceutical products to independent pharmacies and other medical providers. The company was founded in 2008 and is based in Clifton, New Jersey. On February 8, 2017, the voluntary petition of ScripsAmerica, Inc. for reorganization under Chapter 11 was converted to Chapter 7. It had filed for Chapter 11 bankruptcy on September 7, 2016.